Profund Advisors’s Disc Medicine IRON Stock Holding History

Profund Advisors’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$988K	Sell	13,509 -10,463	-44%	-$719K	0.03%	355
2026 Q1	$1.53M	Buy	23,972 +10,494	+78%	+$728K	0.06%	244
2025 Q4	$1.07M	Buy	13,478 +5,360	+66%	+$453K	0.03%	338
2025 Q3	$536K	Buy	8,118 +1,404	+21%	+$83.5K	0.02%	491
2025 Q2	$356K	Sell	6,714 -446	-6%	-$20.9K	0.01%	603
2025 Q1	$355K	Buy	7,160 +1,623	+29%	+$90.2K	0.02%	596
2024 Q4	$351K	Sell	5,537 -1,821	-25%	-$105K	0.01%	690
2024 Q3	$362K	Buy	7,358 +2,772	+60%	+$130K	0.01%	701
2024 Q2	$207K	Sell	4,586 -11,198	-71%	-$381K	0.01%	965
2024 Q1	$983K	Buy	15,784 +9,278	+143%	+$602K	0.04%	362
2023 Q4	$376K	Sell	6,506 -4,046	-38%	-$207K	0.02%	667
2023 Q3	$496K	Buy	+10,552	New	+$528K	0.03%	471

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Profund Advisors's IRON Position: Q2 2026 in Review

Profund Advisors reduced its Disc Medicine (IRON) stake by 44% in Q2 2026, selling an estimated $719K and leaving 13,509 shares worth $988K. The position accounts for 0.03% of the portfolio, ranked #355.

Profund Advisors first reported a position in IRON in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.53M in Q1 2026. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

Profund Advisors held 13,509 shares of Disc Medicine worth $988K as of Q2 2026.
Profund Advisors sold 10,463 Disc Medicine shares in Q2 2026, an estimated $719K.
Disc Medicine made up 0.03% of Profund Advisors's portfolio in Q2 2026, its #355 holding.
Profund Advisors first reported a position in Disc Medicine in Q3 2023 and has held it in 12 quarters since.
Profund Advisors's Disc Medicine position peaked at $1.53M in Q1 2026.
215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.